Effects of VOJTA Technique on Ataxic Cerebral Palsy.
1 other identifier
interventional
40
1 country
1
Brief Summary
Ataxic cerebral palsy (CP) is the least common subtype of CP and it is primarily caused by cerebellar damage that results in hypotonia, impaired balance, poor coordination, tremors, wide-based gait, and significant difficulties in trunk stability and uncontrolled movements. These impairments greatly affect functional mobility and independence in life. This randomized controlled trial aims to evaluate the effects of VOJTA therapy on muscle tone, gross motor function, and postural control in children with ataxic CP aged 2-6 years. VOJTA therapy is based on reflex locomotion, which activates innate central motor programs by stimulating specific pressure zones in defined positions, potentially improving postural alignment and coordinated muscle activation. A total of 40 children will be randomly assigned to either the VOJTA therapy group or a conventional physiotherapy group. Both groups will receive total of 5 sessions per week for 8 weeks and the Outcomes will be measured at baseline, 4 weeks, and 8 weeks using the Modified Ashworth Scale (MAS) for muscle tone, Gross Motor Function Measure (GMFM-88) for gross motor function and Pediatric balance scale for for balance. This study hypothesizes that VOJTA therapy will produce greater improvements in muscle tone, gross motor function and balance as compared to conventional physical therapy techniques. Findings may support evidence-based rehabilitation strategies for ataxic CP and contribute to improved functional independence and quality of life in this understudied population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2025
CompletedStudy Start
First participant enrolled
December 8, 2025
CompletedFirst Posted
Study publicly available on registry
December 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedDecember 30, 2025
December 1, 2025
5 months
December 5, 2025
December 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Modified Ashworth Scale (MAS)
Muscle tone will be evaluated using the Modified Ashworth Scale, which measures resistance during passive movement to assess tone abnormalities. Scores range from 0 to 4, with higher scores indicating increased resistance or greater tone abnormality. Improvement is defined as a reduction in MAS scores or normalization of tone patterns following the intervention period.
Baseline, 4 weeks, 8 weeks
Gross Motor Function Measure-88 (GMFM-88)
Gross motor function will be assessed using the GMFM-88, a validated observational measure designed to evaluate changes in motor skills across five domains (lying/rolling; sitting; crawling/kneeling; standing; walking/running/jumping). Total and domain-specific scores will be analyzed. Improvement is defined as an increase in GMFM-88 scores after the intervention.
Baseline, 4 weeks, 8 weeks
Pediatric Balance Scale (PBS)
Balance performance will be measured using the Pediatric Balance Scale, which includes 14 tasks assessing static and dynamic balance in functional positions. Scores range from 0 to 56, with higher scores representing better balance control. Improvement is defined as an increase in PBS scores following treatment.
Baseline, 4 weeks, 8 weeks
Study Arms (2)
Group 1/ VOJTA
EXPERIMENTALParticipants in this arm will receive VOJTA reflex locomotion therapy, which involves activating innate locomotor patterns through manual stimulation of specific pressure zones while the child is positioned in standardized postures. This arm examines the effectiveness of VOJTA therapy in improving muscle tone, balance, and gross motor function in children with ataxic cerebral palsy
Group 2 / Conventional Physical Therapy
ACTIVE COMPARATORParticipants in this arm will receive routine conventional physiotherapy commonly used for cerebral palsy rehabilitation. This includes Neurodevelopmental Therapy (NDT/Bobath-based methods), balance training, core strengthening, stretching, and functional task-oriented exercises. This arm serves as the comparison group.
Interventions
VOJTA therapy will be administered by a physiotherapist. The intervention involves mechanical stimulation of defined reflex zones located on the trunk and limbs while the child is in prone, supine, or side-lying postures. Stimulation elicits automatic reflex creeping or reflex rolling patterns that enhance trunk activation, postural control, coordination, and normalization of muscle tone. Treatment follows the standardized VOJTA protocol, applying precise direction, pressure, and duration of stimulation. The frequency will be 5 sessions per week for 8 weeks with duration of 30 minutes.
Conventional physiotherapy includes evidence-based approaches commonly applied for cerebral palsy rehabilitation. This may include NDT/Bobath principles, balance and postural stability exercises, core strengthening, stretching, functional mobility training, and sensory-motor facilitation. No VOJTA stimulation will be used. All participants follow a standardized treatment protocol to ensure consistency. The frequency will be 5 sessions per week for 8 weeks with duration of 30 minutes.
Eligibility Criteria
You may qualify if:
- Both male and female participants would be included
- Children diagnosed with ataxic cerebral palsy.
- Age range of participants will be 2 to 6 years old.
- Participants included will be at level 2 on gross motor function classification scale.
- Participants included will have ATNR reflex.
- Stable medical condition for the past three months with no hospitalizations.
You may not qualify if:
- Presence of severe comorbidities i.e. neurological or orthopedic conditions.
- Patients having significant cognitive deficits
- Down syndrome, hydrocephalus, epilepsy, autism and medically ill children
- Children with visual or auditory deficits affecting postural control and balance assessment.
- Ongoing pharmacological treatment (e.g., muscle relaxants or antiepileptic) likely to influence muscle tone or motor function during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physical Therapy
Lahore, Punjab Province, 33351, Pakistan
Related Publications (2)
Ha SY, Sung YH. Effects of Vojta approach on diaphragm movement in children with spastic cerebral palsy. J Exerc Rehabil. 2018 Dec 27;14(6):1005-1009. doi: 10.12965/jer.1836498.249. eCollection 2018 Dec.
PMID: 30656162RESULTSanchez-Gonzalez JL, Sanz-Esteban I, Menendez-Pardinas M, Navarro-Lopez V, Sanz-Mengibar JM. Critical review of the evidence for Vojta Therapy: a systematic review and meta-analysis. Front Neurol. 2024 Apr 22;15:1391448. doi: 10.3389/fneur.2024.1391448. eCollection 2024.
PMID: 38711552RESULT
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2025
First Posted
December 18, 2025
Study Start
December 8, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
December 30, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share